General
Preferred name
NICLOSAMIDE
Synonyms
Niclosamide (monohydrate) ()
BAY2353 monohydrate ()
Niclosamide-olamine ()
Niclosamide Ethanolamine salt ()
BAY2353 ()
Niclocide ()
Niclosamide monohydrate ()
Niclosamide (olamine) ()
Niclosamide olamine ()
Niclosamide (BAY2353) ()
Niclocide, NSC 178296 ()
BAY2353 (olamine) ()
NSC-178296 ()
Lintex ()
Niclosamida ()
WR 46234 ()
Niclosamidum anhydrous ()
Niclosamide anhydrous ()
BAY-2353 ()
Nicloside ()
Niclosamide, anhydrous ()
Niclosamide (anhydrous) ()
Yomesan ()
BAY 2353 ()
Ex A Lint ()
Niclosamide (ethanolamine salt) ()
P&D ID
PD001014
CAS
50-65-7
1420-04-8
73360-56-2
Tags
available
drug
Approved by
FDA
Drug indication
Cestodes infection
metastatic prostate cancer
Drug Status
vet_approved
approved
investigational
withdrawn
Max Phase
4.0
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Niclosamide is an oral anthelmintic drug but may have the potential to be used in broader clinical applications. Evidence from repurposing studies suggests some activity against methicillin-resistant Staphylococcus aureus (MRSA), and Zika virus (in vitro) .
It is a STAT3 inhibitor, inhibits mTORC1 signaling; positive allosteric modulator (PAM) of the neuropeptide Y4 receptor . (GtoPdb)
It is a STAT3 inhibitor, inhibits mTORC1 signaling; positive allosteric modulator (PAM) of the neuropeptide Y4 receptor . (GtoPdb)
DESCPRITION
An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
PRICE
29
DESCRIPTION
Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research[1]. Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 ¦ÌM in HeLa cells[4]. Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells[2][3][5].
PRICE
29
DESCRIPTION
Niclosamide (BAY2353) olamine is an orally active antihelminthic agent used in parasitic infection research[1]. Niclosamide olamin is a STAT3 inhibitor with an IC50 of 0.25 ¦ÌM in HeLa cells[4]. Niclosamide olamin has biological activities against cancer, and inhibits DNA replication in Vero E6 cells[2][3][5].
DESCRIPTION
inhibitor of STAT3 signaling
(Informer Set)
DESCRIPTION
Niclosamide is an anthelmintic that disrupts mitochondrial metabolism in parasitic worms and animal models. It inhibits STAT3 and stimulates autophagy by reversibly inhibiting mammalian target of rapamycin complex 1 signaling.
(Enamine Bioactive Compounds)
DESCRIPTION
Protein synthesis inhibitor
(Tocris Bioactive Compound Library)
DESCRIPTION
Protonophoric anthelmintic; uncouples oxidative phosphorylation
(LOPAC library)
DESCRIPTION
Niclosamide is an oral antihelminthic drug, which has been used to treat tapeworm infection for about 50 years. Niclosamide is also used as a molluscicide for water treatment in schistosomiasis control programs. Recently, several groups have independently discovered that niclosamide is also active against cancer cells. Evidence supports that niclosamide targets multiple signaling pathways (NF-κB, Wnt/β-catenin, Notch, ROS, mTORC1, and Stat3), most of which are closely involved with cancer stem cells. Given its potential antitumor activity, clinical trials for niclosamide and its derivatives are warranted for cancer treatment. It can be used for tapeworm disease in livestock and poultry, and fasciasis in ruminants.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Niclosamide (Niclocide)(BAY2353) is used to treat most tapeworm infections by inhibiting DNA replication.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Niclosamide is an oral antihelminthic drug, which has been used to treat tapeworm infection for about 50 years. Niclosamide is also used as a molluscicide for water treatment in schistosomiasis control programs. Recently, several groups have independently discovered that niclosamide is also active against cancer cells. Evidence supports that niclosamide targets multiple signaling pathways (NF-κB, Wnt/β-catenin, Notch, ROS, mTORC1, and Stat3), most of which are closely involved with cancer stem cells. Given its potential antitumor activity, clinical trials for niclosamide and its derivatives are warranted for cancer treatment.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Niclosamide olamine (Niclosamide Ethanolamine salt) is an Repellent, Insect Attractant and Chemosterilant.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Niclosamide Monohydrate is used for the treatment of most tapeworm infections by inhibiting DNA replication. It inhibits the TNF-induced NF-κB reporter activity in a dose- and time-dependent manner in U2OS cells. It also inhibits TNF-induced degradation of IκBα and relocation of p65 in a dose- and time-dependent manner in HL-60, Molm13, or AML primary cells.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
30
Organisms
10
Compound Sets
35
BOC Sciences Bioactive Compounds
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Informer Set
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
Nuisance compounds in cellular assays
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
129
Molecular Weight
325.99
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
3.86
TPSA
92.47
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.66
Structural alerts
3
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Nonspecific/NOS
Nuisance compounds
Custom attributes
(extracted from source data)
Target
STAT3
STAT
DNA
antibiotic
Parasite
Autophagy,STAT
Environmental Pollutants
Compound status
FDA
Selectivity
Protonophore
Pathway
JAK/STAT Signaling
Stem Cell/Wnt
Autophagy
Microbiology/virology
Stem Cells
Anti-infection
MOA
Unknown molecular target
Inhibitor
DNA replication inhibitor, STAT inhibitor
Primary Target
STATs
Indication
tapeworm
ATC
P02DA01
Source data

